Open Access

Invasive ventilation modes in children: a systematic review and meta-analysis

  • Anita Duyndam1,
  • Erwin Ista1Email author,
  • Robert Jan Houmes1,
  • Bionda van Driel1,
  • Irwin Reiss1 and
  • Dick Tibboel1
Critical Care201115:R24

Received: 7 June 2010

Accepted: 17 January 2011

Published: 17 January 2011



The purpose of the present study was to critically review the existing body of evidence on ventilation modes for infants and children up to the age of 18 years.


The PubMed and EMBASE databases were searched using the search terms 'artificial respiration', 'instrumentation', 'device', 'devices', 'mode', and 'modes'. The review included only studies comparing two ventilation modes in a randomized controlled study and reporting one of the following outcome measures: length of ventilation (LOV), oxygenation, mortality, chronic lung disease and weaning. We quantitatively pooled the results of trials where suitable.


Five trials met the inclusion criteria. They addressed six different ventilation modes in 421 children: high-frequency oscillation (HFO), pressure control (PC), pressure support (PS), volume support (VS), volume diffusive respirator (VDR) and biphasic positive airway pressure. Overall there were no significant differences in LOV and mortality or survival rate associated with the different ventilation modes. Two trials compared HFO versus conventional ventilation. In the pooled analysis, the mortality rate did not differ between these modes (odds ratio = 0.83, 95% confidence interval = 0.30 to 1.91). High-frequency ventilation (HFO and VDR) was associated with a better oxygenation after 72 hours than was conventional ventilation. One study found a significantly higher PaO2/FiO2 ratio with the use of VDR versus PC ventilation in children with burns. Weaning was studied in 182 children assigned to either a PS protocol, a VS protocol or no protocol. Most children could be weaned within 2 days and the weaning time did not significantly differ between the groups.


The literature provides scarce data for the best ventilation mode in critically ill children beyond the newborn period. There is no evidence, however, that high-frequency ventilation reduced mortality and LOV. Longer-term outcome measures such as pulmonary function, neurocognitive development, and cost-effectiveness should be considered in future studies.


Ventilator-induced lung injury in critically ill children suffering from acute respiratory failure should be counteracted by adapting ventilation management to the cause of respiratory failure [1]. Ideally, management should be based on proven effective strategies. In a multicenter study, bronchiolitis was the most frequent cause of respiratory failure in infants (43.6%); pneumonia the most frequent cause in older children (24.8%) [2]. Mortality in that study was rare (1.6%); the median duration of ventilation was 7 days. Randolph suggested that in pediatric clinical trials long-term morbidity would be a more sensitive indicator of the effects of clinical ventilation interventions than would mortality or duration of ventilation [1].

Pediatric intensive care units worldwide use a wide variety of ventilation modes: high-frequency oscillation (HFO), pressure control (PC), synchronized intermittent mandatory ventilation, pressure support (PS), pressure-regulated volume control and, more recently, neurally adjusted ventilator assist [3, 4]. The ventilation mode is often not targeted specifically to the underlying disease but rather is determined by the intensive care physician's experience, local pediatric intensive care unit policy and protocols, or outcomes of studies in adults [1, 2, 5]. An unambiguous international guideline is still lacking [1, 5].

The objective of the present article is to systematically review the randomized controlled trials (RCTs) comparing ventilation modes used in critically ill children (from term born up to 18 years of age) on the following outcome measures: length of ventilation, oxygenation, mortality, chronic lung disease and weaning. We aimed to determine whether there is sufficient evidence to decide on the better mode.

Materials and methods

Search and selection

A systematic search was performed in the PubMed and EMBASE databases in September 2010. MeSH terms and keywords searched for in the titles, abstracts and keywords areas were 'artificial respiration', 'instrumentation', 'device', 'devices', 'mode', and 'modes', combined with the Boolean operators AND, OR. (Additional file 1 provides the complete search strategy.) The search was limited to RCTs or quasi-experimental studies, with age limit >28 days until 18 years. Only articles comparing at least two ventilation modes were selected for review. Articles on non-invasive ventilation, studies in premature neonates (< 37 weeks) and articles in other languages than English or Dutch were excluded. No limits were imposed on the publication date.

Two authors (AD, EI) independently reviewed abstracts and full-text articles to identify eligible studies. Reference lists of retrieved studies were hand-searched for additional articles.

Quality assessment

The study quality and level of evidence were assessed on criteria established by the Dutch Institute for Healthcare Improvement CBO in collaboration with the Dutch Cochrane library (see Additional file 2 and Table 1) [6]. The major criteria were as follows: Was assignment to the study group randomized? Were investigators blinded? Was it an intention-to-treat analysis? Were the study groups comparable? Was there appropriate report of outcome results for each group and the estimated effect size? Consensus between the authors on the interpretation of the extracted data was achieved.
Table 1

Level of evidence


Description of evidence


High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias


Well-conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias


Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias


High-quality systematic reviews of case-control or cohort studies; or high-quality case-control or cohort studies with a very low risk of confounding, bias, or chance and a high probability that the relationship is causal


Well-conducted case-control or cohort studies with a low risk of confounding, bias, or chance and a moderate probability that the relationship is causal


Case-control or cohort studies with a high risk of confounding, bias or chance, and a significant probability that the relationship is not causal


Non-analytic studies; for example, case reports, case series


Expert opinion

RCT, randomized controlled trial.

Data abstraction

Authors AD and EI each independently recorded patient characteristics (sample size, age, respiratory failure), details of the ventilation mode and the period over which outcome variables were measured. Outcome variables considered were the following: length of ventilation (LOV), oxygenation, chronic lung disease, mortality and weaning.

Statistical methods

We quantitatively pooled the results of individual trials, where suitable. We expressed the treatment effect as an odds ratio (OR) for dichotomous outcomes and as a weighted mean difference (WMD) for continuous outcomes with 95% confidence intervals (CIs). The pooled OR was estimated with the Mantel-Haenszel method, which is generally the most robust model [7]. Differences were considered statistically significant if P < 0.05 or if the 95% confidence interval did not include the value 1. The analyses were performed with Microsoft® Excel, Office 2007 for Windows.


Search and selection

After filtering out duplicate studies, the titles and abstracts of 461 potentially relevant articles were screened (Figure 1). The reference lists yielded one other study that had been missed because the keywords were not in the title or abstract. Eventually, nine full-text articles were retrieved and assessed for eligibility. Four RCTs were excluded for any of the following reasons: focus on triggering instead of ventilation, inclusion of infants below 37 weeks of gestational age, or not comparing two ventilation modes [811]. The present review therefore includes five RCTs [1216].
Figure 1

Search results. RCT, randomized controlled trial.

Tabulated details of these five RCTs are presented in Tables 2 and 3.
Table 2

Included randomized controlled trials - ventilation


Study population


Outcome measures

Level of evidence



LOV (days)




Arnold and colleagues [12]

58 children (age: HFO 2.5 ± 2.5 vs. CV 3.1 ± 3.3 years) with diffuse alveolar disease and/or airleak syndrome

Multicenter study (five centers)

Number of survivors at 30 days - CV: 17 of 29 (59%); HFO: 19 of 29 (66%) (NS)

Total - CV: 22 ± 17; HFO: 20 ± 27

PaO2/PAO2 increase over time (72 hours) in HFO compared with CV (P < 0.001)

CV: n = 10 (59%); HFO: n = 4 (21%) (P = 0.039; OR = 5.4 95% CI = 1.2 to 23.2) (O2 at 30 days)



Comparison effectiveness of HFO (n = 29) with CV (n = 29) - crossover

Death (ranked) - CV: 40%, CV to HFO: 42%, HFO: 6%, HFO to CV: 82% (P ≤0.001)

Survivors (at 30 days) - CV: 29 ± 18; HFO: 27 ± 31.

PaO2/PAO2 - HFO: 0.13 (0 hours) up to 0.26 (72 hours); CV: 0.13 (0 hours) up to 0.22 (72 hours)


Crossover: CV to HFO (n = 19), HFO to CV (n = 11)


Nonsurvivors (at 30 days) - CV: 11 ± 9; HFO: 8 ± 6 (NS)

After crossover - PaO2/PAO2 increase over time (72 hours) in CV to HFO group compared with HFO to CV group (P = 0.003)


Dobyns and colleagues [14]

99 children (age 0 to 23 years) with AHRF, oxygenation index >15

Multicenter study (seven centers)

Trend of improved survival in HFO + iNO - CV: 22 of 38 (58%); CV + iNO: 20 of 35 (53%); HFO: 7 of 12 (58%); HFO + iNO: 10 of 14 (71%) (P = 0.994)

CV: 22 ± 4; CV + iNO: 21 ± 3; HFO: 52 ± 28; HFO + iNO: 17 ± 4 (P = 0.098)

PaO2/FiO2 (PF) ratio - after 4 hours: HFO + iNO 136 ± 21 vs. CV 96 ± 6 (P = 0.2); after 12 hours: HFO + iNO 184 ± 45 vs. CV 107 ± 8 and CV + iNO 115 ± 9, HFO 136 ± 32 (P = 0.023); after 24 hours: treatment both HFO + iNO and HFO resulted in greater improvement in PF ratio than CV or CV + iNO (P = 0.005); after 72 hours: HFO 259 ± 60 vs. CV 148 ± 15 and CV + iNO 150 ± 19; HFO + iNO 213 ± 29 (P = 0.027)




Comparisons between patients treated with HFO + iNO (n = 14), HFO alone (n = 12), CV + iNO (n = 35), and CV alone (n = 38)


Jaarsma and colleagues [13]

18 children (age 0 to 10 years) with respiratory failure for ventilation

Single-center study


BIPAP: 9.8 ± 9.2; PS: 6.4 ± 5.8 (P = 0.27)





Compare BIPAP (n = 11) with PS (n = 7), determining which mode is effective, safe and easy


Carman and colleagues [16]

64 children (age 7.4 ± 0.7 years) with inhalation injury

Single-center study

VDR: 2/32 (6%); PC: 5/32 (16%) (NS)

VDR: 12 ± 2; PCV: 11 ± 2 (NS)

PF ratio - VDR: 563 ± 16; PC: 507 ± 13 (P < 0.05)




Compare VDR (n = 32) with PC (n = 32)


Data presented as number/total (percentage) or mean ± standard deviation. AHRF, acute hypoxemic respiratory failure; BIPAP, biphasic positive airway pressure; CI, confidence interval; CLD, chronic lung disease; CV, conventional mechanical ventilation; HFO, high-frequency oscillation ventilation; iNO, inhaled nitric oxide; LOV, length of ventilation; ND, no data; NS, not significant; OR; odds ratio; VDR, volume diffusive respirator (high-frequency time-cycled pressure ventilator); PC, pressure-controlled ventilation; PS, pressure support ventilation.

Table 3

Included randomized controlled trials- weaning


Study population


Outcome measures

Level of evidence


Duration of weaning (days)a

Extubation failure rate



Randolph and colleagues [15]

182 children (age 0 to 17 years) with weaning of ventilation support for more than 24 hours and who failed a test for extubation readiness on minimal PS

Multicenter study (10 centers) to evaluate weaning protocols comparing VS (continuous automated adjustment of PS by the ventilator) (n = 59) and PS (adjustment by clinicians) (n = 61) with standard care (no protocol) (n = 59)

PS: 1.6 (0.9 to 4.1); VS: 1.8 (1.0 to 3.2); no protocol: 2.0 (0.9 to 2.9) (P = 0.75)

PS (15%), VS (24%); no protocol (17%) (P = 0.44). Male children more frequently failed extubation (OR = 7.86 95% CI = 2.36 to 26.2; P < 0.001)



aData presented as median (interquartile range). CI, confidence interval; ND, no data; OR, odds ratio; PS, pressure support; VS, volume support.

Length of ventilation

The LOV served as the outcome measure in four studies (Table 2). First, Arnold and colleagues in a multicenter trial compared HFO and conventional ventilation (CV) in 58 children with either diffuse alveolar disease and/or air leak syndrome; 29 had been randomized to HFO, and 29 to CV [12]. During the first 72 hours of study, the mean airway pressure was significantly (P < 0.001) higher in the HFO group. The HFO strategy entailed aggressive increases in mean airway pressure to attain the ideal lung volume and to achieve an arterial oxygen saturation >90% with FiO2 < 0.6. The CV strategy entailed stepping up the end-expiratory pressure and inspiratory time to increase the mean airway pressure and to limit peak inspiratory pressure increases. Crossover to the alternate ventilator was required if the patient met defined criteria for treatment failure. LOV did not significantly differ between the CV and HFO groups (WMD = 2.0 days, 95% CI = -9.61 to 13.61).

Second, Dobyns and colleagues in a multicenter study compared HFO and CV in 99 children with acute hypoxemic respiratory failure [14]. Seventy-three children were treated with CV (38 without inhaled nitric oxide (iNO), 35 with iNO), and 26 with HFO (12 without iNO, 14 with iNO). Mechanical ventilation and FiO2 were adjusted to maintain SaO2 at 90% and pCO2 between 45 and 55 mmHg. Higher pCO2 values were tolerated as long as the arterial pH was 7.20. In the CV strategy, the positive end-expiratory pressure was increased incrementally to improve oxygenation while avoiding clinical and radiographic signs of lung hyperinflation. The peak airway pressure was maintained at <35 to 40 cmH2O by limiting the level of tidal volume and positive end-expiratory pressure. The initial HFO settings were: FiO2 of 1.0, 33% inspiratory time, frequency of 10 Hz, and mean airway pressure set at 2 to 4 cmH2O above that used on CV. The pressure amplitude was set to achieve perceptible chest wall motion and was adjusted if possible to optimize ventilation. In this study HFO did not lead to a significantly shorter LOV (Table 2). For the two ventilation groups without iNO, however, the LOV significantly differed between CV and HFO (WMD = -30.0 days, 95% CI = -45.89 to -14.11).

Third, Carman and colleagues compared the volume diffusive respirator (VDR) with PC ventilation in burned children with inhalation injury [16]. The VDR is a high-frequency, time-cycled pressure ventilator that can ventilate, oxygenate and promote secretion removal. SaO2 was maintained at or above 90%; PaCO2 was maintained at <55 mmHg. Thirty-two children with a mean ± standard deviation age of 5.5 ± 0.9 years were treated with VDR, and 32 children with a mean ± standard deviation age of 9.4 ± 1.0 years were treated with PC ventilation (P = 0.04 for mean age). The LOV was significantly different between the study groups (WMD = -1.0 days, 95% CI = -1.98 to -0.02).

Fourth, Jaarsma and colleagues randomized 18 children with respiratory failure to either biphasic positive airway pressure (n = 11) or pressure support ventilation (n = 7); their median age was 4 months (range 4 weeks to 10 years) [13]. Initial ventilator settings depended on age and the cause of respiratory failure, and were adjusted according to thoracic excursions and the measured tidal volume. Adjustments were made afterwards aiming at a pCO2 of 4 to 5 kPa and a pO2 of 8 to 11 kPa. The LOV did not significantly differ between biphasic positive airway pressure (9.8 ± 9.2 days) and PS (6.4 ± 5.8 days).

Pooled analysis of these trials resulted in a significantly shorter LOV after CV in comparison with HFO (WMD = -2.3 days, 95% CI = -3.63 to -1.04) (Table 4).
Table 4

Meta-analysis of trials comparing high-frequency ventilation with conventional ventilation: length of ventilation




WMD (95% CI)

Zvalue (Pvalue)


Mean (SD)


Mean (SD)



Arnold and colleagues [12]

22 (17)


20 (27)


2 (-9.61 to 13.61)

-0.338 (0.74)

Dobyns and colleagues [14]

22 (4)


52 (28)


-30 (-45.89 to -14.11)

3.699 (0.0002)






-11.51 (-15.14 to -7.88)

-6.221 (< 0.0001)

Carman and colleagues (VDR) [16]

11 (2)


12 (2)


-1 (-1.98 to -0.02)

-2.0 (0.046)






-2.34 (-3.63 to -1.04)

-3.542 (0.0004)

CI, confidence interval; CV, conventional ventilation; HFOV, High-frequency oscillation ventilation; SD, standard deviation; VDR, volume diffusive respirator (high-frequency time-cycled pressure ventilator); WMD, weight mean difference.


Three studies addressed the effects of different ventilation modes on oxygenation.

In the study by Dobyns and colleagues, the PaO2/FiO2 (PF) ratio improved most in the HFO mode with iNO after 4 hours (136 ± 21 mmHg vs. CV 96 ± 6 mmHg; P = 0.2) and after 12 hours (HFOV + iNO 184 ± 45 mmHg vs. CV 107 ± 8 mmHg and CV + iNO 115 ± 9 mmHg, P = 0.023; HFOV 136 ± 32 mmHg) [14]. After 24 hours, HFO treatment both with and without iNO provided better oxygenation than CV both with and without iNO (P < 0.05). After 72 hours, HFO treatment was associated with the best improvement in PF ratio (HFO 259 ± 60 mmHg vs. CV 148 ± 15 mmHg and CV + iNO 150 ± 19 mmHg, P = 0.027; HFOV + iNO 213 ± 9 mmHg). The two therapies did not differ in failure rate. Arnold and colleagues reported a significant (P = 0.001) relationship between time and a decreasing oxygenation index in the HFO group but not in the CV group [12]. After crossover (19 patients crossed over from CV to HFO and 11 patients crossed over from HFO to CV) this relationship was significant in both crossover groups (P = 0.03 crossover to CV; P = 0.02 crossover to HFO).

Carman and colleagues reported a significantly higher PF ratio in the VDR mode compared with PC (563 ± 15 mmHg vs. 507 ± 13 mmHg, P < 0.05) but did not specify the time point at which the best PF ratio was measured [16]. As the oxygenation parameters in these three studies were not uniform it was not possible to pool the data.

Mortality and survival

Three studies focused on the outcome measure of mortality or survival.

None found a significant difference in mortality between patients treated with HFO and those treated with CV. Arnold and colleagues reported a mortality rate of 34% (10/29) for HFO versus 41% (12/29) for CV (OR = 0.75, 95% CI = 0.26 to 2.16) [12]. The mortality rate in patients not crossed over to CV from HFO or to HFO from CV, however, was significantly better (P = 0.003) than that in patients managed with CV only.

Dobyns and colleagues showed that the survival rate for patients treated with HFO in combination with iNO was higher than that for patients treated with HFO only or with CV (71% vs. 58% in CV, 53% in CV + iNO and 58% in HFO) [14]. These differences did not achieve statistical significance. These authors speculated that the improved lung recruitment by HFO enhances the effects of low-dose iNO on gas exchange. The mortality rate for HFO without iNO was 42% (5/12) versus 42% (16/38) for CV without iNO (OR = 0.98, 95% CI = 0.26 to 3.66) [14]. In the study by Carman and colleagues, five out of 32 (16%) patients in the PCV group died versus two out of 32 (6%) in the VDR group (OR = 0.36, 95% CI = 0.06 to 2.01) [16].

In the pooled analysis, the mortality rates in the HFO mode and in CV did not differ (OR = 0.70, 95% CI = 0.33 to 1.47) (Table 5).
Table 5

Meta-analysis of trials comparing high-frequency ventilation with conventional ventilation: mortality


Conventional ventilation

High-frequency oscillation ventilation

Odds ratio (95% confidence interval)

Arnold and colleagues [12]



0.75 (0.26 to 2.16)

Dobyns and colleagues [14]



0.98 (0.26 to 3.66)

Subtotal Mantel-Haenszel



0.83 (0.30 to 1.91)

Carman and colleagues (VDR) [16]




Overall Mantel-Haenszel



0.70 (0.33 to 1.47)

Data presented as number/total. VDR, volume diffusive respirator (high-frequency time-cycled pressure ventilator).

Chronic lung disease

Chronic lung disease was examined only in the study by Arnold and colleagues [12]. The proportion of patients treated with HFO and requiring supplemental oxygen at 30 days was lower than that of patients managed with CV (P = 0.039; OR = 5.4, 95% CI = 1.2 to 23.2).


Randolph and colleagues randomized 182 children aged from 0 to 17 years to either a PS protocol (n = 62), a volume support (VS) protocol (n = 60) or a no ventilation weaning protocol in which weaning was at the discretion of the physician (n = 60) (Table 3) [15]. The VS and PS protocols dictated that FiO2 and positive end-expiratory pressure be adjusted to maintain SpO2 at 95% or higher. In the PS protocol, the amount of pressure support was adjusted to achieve an exhaled tidal volume goal of 5 to 7 ml/kg. In the VS protocol, the ventilator automatically adjusted the level of PS to achieve an exhaled tidal volume of 5 to 7 ml/kg.

Two outcome measures were assessed: weaning time and extubation failure (that is, any invasive or non-invasive ventilator support within 48 hours of extubation). The authors hypothesized that VS would result in a shorter weaning time as the inspiratory pressures automatically decrease with improvement of lung compliance. Most children could be weaned within 2 days and the weaning time did not significantly differ for the protocols used: PS, 1.6 days; VS, 1.8 days; and no protocol, 2.0 days. Extubation failure rates were not significantly different for PS (15%), VS (24%) and no protocol (17%).

Quality of studies

These five studies compared six different ventilation modes in 421 children [1214, 16]. Two studies, based on an intention-to-treat analysis, met all CBO quality criteria [14, 15]. Blinding was not possible in any of these studies, because ventilator displays cannot be masked. In four studies, patient characteristics and prognostic variables did not differ between the intervention groups. In the study by Carman and colleagues, the mean age differed significantly [16]. Only one study calculated the estimated effect sizes (relative risk of OR) for continuous outcome variables such as LOV, survival or weaning failure [15]. The study by Dobyns and colleagues [14] is of limited quality because it is a secondary analysis of data obtained from a previous multicenter, randomized trial on iNO treatment in pediatric acute hypoxemic respiratory failure [8]. The mode of ventilation was determined by the attending physician with the guidance of guidelines to maximize oxygenation. The patient was then randomized to treatment with or without iNO [14]. Levels of evidence for the different studies are presented in Tables 2 and 3.


The present review aimed at identifying the various ventilation modes used in children over the past three decades, searching for any data that would favor a particular mode for pediatric ventilation. The five RCTs included in this review varied in the investigated modes of ventilations, in outcomes and in patient groups.

High-frequency ventilators may use different ventilation modes. Two studies included in the present review concerned HFO ventilation [12, 14]; a third concerned the VDR (high-frequency, time-cycled pressure ventilator) [16]. The evidence from these studies does not allow making a recommendation on the preferred type of high-frequency ventilator. Two RCTs compared HFO with CV on the outcomes oxygenation, LOV and mortality. Neither study found significant differences in mortality and LOV. Analysis of the pooled data, however, revealed a significantly lower LOV for the CV groups. A confounding factor for this finding is the threefold sample size of conventionally ventilated patients in the study by Dobyns and colleagues [14]. On the other hand, this analysis only concerned patients treated with HFO and CV without iNO.

In all studies, oxygenation significantly improved over 72 hours for patients treated with high-frequency oscillators [12, 14, 16]. A lack of uniform data on oxygenation, however, prevented analysis of pooled data. This finding is in contrast with that reported for preterm neonates. The systematic reviews and meta-analyses overall provide no evidence that HFO as the initial ventilation strategy offers important advantages over CV in terms of preventing chronic lung disease in preterm infants with acute pulmonary dysfunction [1722].

The level of evidence proved moderate to good in three studies [12, 14, 15]. The study by Jaarsma and colleagues was stopped halfway through as both physicians and nurses preferred biphasic positive airway pressure [13]. This was designated level 1 evidence because of the high risk of bias. Likewise, the study by Carman and colleagues was designated level 1 evidence because the randomization failed for the demographic variable age [16].

The strengths of the present review include a comprehensive search strategy, broad inclusion criteria (resulting in a representative, heterogeneous population) and assessment of clinically important outcomes. In addition, we pooled the data. This statistical approach is also allowed for quasi-experimental, nonrandomized studies - such as the study by Dobyns and colleagues [14] - in which randomization of groups was not possible or failed [23]. Meta-analytic techniques in the analysis of nonrandomized studies have been criticized for their potential to perpetuate the individual biases of each study and to give a false impression of cohesion in the literature, thus discouraging further research [24]. The counter-argument is that statistical quantification and pooling of results from many studies helps to identify reasons for variability, inconsistency or heterogeneity in the literature, and thus may encourage further research [23, 25]. Nevertheless, the pooled results of the present study should be interpreted cautiously in view of the diversity in patient groups, sample sizes, randomization methods, types of ventilators and ventilation strategies.

The reviewed RCTs cannot easily be compared owing to the heterogeneity in age, underlying disease and study outcomes. We would therefore recommend setting up studies investigating the best ventilation strategy for specific age categories or underlying pathology [1]. Furthermore, as mortality is rather low, longer-term outcome measures others than the short-term outcome measures studied in the present review should be considered, such as pulmonary function, neurocognitive development and cost-effectiveness. Internationally consensus on the most appropriate outcome measures should be reached.


The available literature does not provide sufficient evidence on the best ventilation mode in critically ill children beyond the newborn period. High-frequency ventilation (HFO and VDR) provided better oxygenation after 72 hours than did CV. There is no evidence that high-frequency ventilation would reduce mortality and LOV.

Key messages

  • There is no evidence for the best ventilation mode in critically ill children beyond the newborn period up to 18 years.

  • The different modes have not yet been investigated in (large) groups of children.

  • Oxygenation significantly improved over 72 hours for patients treated with high-frequency oscillators.

  • Longer-term outcome measures such as pulmonary function and neurocognitive development should be considered.



confidence interval


conventional ventilation


fraction of inspired oxygen


high-frequency oscillation


inhaled nitric oxide


length of ventilation


odds ratio


pressure control


partial arterial pressure of carbon dioxide


PaO2/FiO2 ratio


partial pressure of oxygen


pressure support


randomized controlled trial


saturation of oxygen


volume diffusive respirator


volume support


weighted mean difference.



The authors thank Ko Hagoort for editing the manuscript. They also thank Prof. Dr H Boersma for statistical advice.

Authors’ Affiliations

Intensive Care Unit, Erasmus MC - Sophia Children's Hospital


  1. Randolph AG: Management of acute lung injury and acute respiratory distress syndrome in children. Crit Care Med. 2009, 37: 2448-2454. 10.1097/CCM.0b013e3181be7b72.PubMedView ArticleGoogle Scholar
  2. Randolph AG, Meert KL, O'Neil ME, Hanson JH, Luckett PM, Arnold JH, Gedeit RG, Cox PN, Roberts JS, Venkataraman ST, Forbes PW, Cheifetz IM: The feasibility of conducting clinical trials in infants and children with acute respiratory failure. Am J Respir Crit Care Med. 2003, 167: 1334-1340. 10.1164/rccm.200210-1175OC.PubMedView ArticleGoogle Scholar
  3. Bengtsson JA, Edberg KE: Neurally adjusted ventilatory assist in children: an observational study. Pediatr Crit Care Med. 2010, 11: 253-257. 10.1097/PCC.0b013e3181b0655e.PubMedView ArticleGoogle Scholar
  4. Breatnach C, Conlon NP, Stack M, Healy M, O'Hare BP: A prospective crossover comparison of neurally adjusted ventilatory assist and pressure-support ventilation in a pediatric and neonatal intensive care unit population. Pediatr Crit Care Med. 2010, 11: 7-11. 10.1097/PCC.0b013e3181b0630f.PubMedView ArticleGoogle Scholar
  5. Turner DA, Arnold JH: Insights in pediatric ventilation: timing of intubation, ventilatory strategies, and weaning. Curr Opin Crit Care. 2007, 13: 57-63. 10.1097/MCC.0b013e32801297f9.PubMedView ArticleGoogle Scholar
  6. CBO: Evidence-based Richtlijnontwikkeling. Handleiding voor werkgroepleden. 2007, Kwaliteitsinstituut voor de Gezondheidszorg CBOGoogle Scholar
  7. Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res. 1993, 2: 121-145. 10.1177/096228029300200202.PubMedView ArticleGoogle Scholar
  8. Dobyns EL, Cornfield DN, Anas NG, Fortenberry JD, Tasker RC, Lynch A, Liu P, Eells PL, Griebel J, Baier M, Kinsella JP, Abman SH: Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999, 134: 406-412. 10.1016/S0022-3476(99)70196-4.PubMedView ArticleGoogle Scholar
  9. Guthrie SO, Lynn C, Lafleur BJ, Donn SM, Walsh WF: A crossover analysis of mandatory minute ventilation compared to synchronized intermittent mandatory ventilation in neonates. J Perinatol. 2005, 25: 643-646. 10.1038/ ArticleGoogle Scholar
  10. Thiagarajan RR, Coleman DM, Bratton SL, Watson RS, Martin LD: Inspiratory work of breathing is not decreased by flow-triggered sensing during spontaneous breathing in children receiving mechanical ventilation: a preliminary report. Pediatr Crit Care Med. 2004, 5: 375-378. 10.1097/01.PCC.0000128604.69914.60.PubMedView ArticleGoogle Scholar
  11. Rojas MA, Lozano JM, Rojas MX, Bose CL, Rondon MA, Ruiz G, Pineros JG, Rojas C, Robayo G, Hoyos A, Celis LA, Torres S, Correa J: Randomized, multicenter trial of conventional ventilation versus high-frequency oscillatory ventilation for the early management of respiratory failure in term or near-term infants in Colombia. J Perinatol. 2005, 25: 720-724. 10.1038/ ArticleGoogle Scholar
  12. Arnold JH, Hanson JH, Toro-Figuero LO, Gutierrez J, Berens RJ, Anglin DL: Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med. 1994, 22: 1530-1539.PubMedView ArticleGoogle Scholar
  13. Jaarsma AS, Knoester H, van Rooyen F, Bos AP: Biphasic positive airway pressure ventilation (PeV+) in children. Crit Care. 2001, 5: 174-177. 10.1186/cc1018.PubMedPubMed CentralView ArticleGoogle Scholar
  14. Dobyns EL, Anas NG, Fortenberry JD, Deshpande J, Cornfield DN, Tasker RC, Liu P, Eells PL, Griebel J, Kinsella JP, Abman SH: Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics. Crit Care Med. 2002, 30: 2425-2429. 10.1097/00003246-200211000-00004.PubMedView ArticleGoogle Scholar
  15. Randolph AG, Wypij D, Venkataraman ST, Hanson JH, Gedeit RG, Meert KL, Luckett PM, Forbes P, Lilley M, Thompson J, Cheifetz IM, Hibberd P, Wetzel R, Cox PN, Arnold JH: Effect of mechanical ventilator weaning protocols on respiratory outcomes in infants and children: a randomized controlled trial. JAMA. 2002, 288: 2561-2568. 10.1001/jama.288.20.2561.PubMedView ArticleGoogle Scholar
  16. Carman B, Cahill T, Warden G, McCall J: A prospective, randomized comparison of the Volume Diffusive Respirator vs conventional ventilation for ventilation of burned children. 2001 ABA paper. J Burn Care Rehabil. 2002, 23: 444-448. 10.1097/00004630-200211000-00011.PubMedView ArticleGoogle Scholar
  17. Bollen CW, Uiterwaal CS, van Vught AJ: Cumulative metaanalysis of high-frequency versus conventional ventilation in premature neonates. Am J Respir Crit Care Med. 2003, 168: 1150-1155. 10.1164/rccm.200306-721CP.PubMedView ArticleGoogle Scholar
  18. Cools F, Henderson-Smart DJ, Offringa M, Askie LM: Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev. 2009, CD000104-3Google Scholar
  19. Bollen CW, Uiterwaal CS, van Vught AJ: Systematic review of determinants of mortality in high frequency oscillatory ventilation in acute respiratory distress syndrome. Crit Care. 2006, 10: R34-10.1186/cc4824.PubMedPubMed CentralView ArticleGoogle Scholar
  20. Bollen CW, Uiterwaal CS, van Vught AJ: Meta-regression analysis of high-frequency ventilation vs conventional ventilation in infant respiratory distress syndrome. Intensive Care Med. 2007, 33: 680-688. 10.1007/s00134-007-0545-y.PubMedPubMed CentralView ArticleGoogle Scholar
  21. Cools F, Askie LM, Offringa M, Asselin JM, Calvert SA, Courtney SE, Dani C, Durand DJ, Gerstmann DR, Henderson-Smart DJ, Marlow N, Peacock JL, Pillow JJ, Soll RF, Thome UH, Truffert P, Schreiber MD, Van Reempts P, Vendettuoli V, Vento G: Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data. Lancet. 2010, 375: 2082-2091. 10.1016/S0140-6736(10)60278-4.PubMedView ArticleGoogle Scholar
  22. Greenough A, Dimitriou G, Prendergast M, Milner AD: Synchronized mechanical ventilation for respiratory support in newborn infants. Cochrane Database Syst Rev. 2008, CD000456-1Google Scholar
  23. MacLehose RR, Reeves BC, Harvey IM, Sheldon TA, Russell IT, Black AM: A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technol Assess. 2000, 4: 1-154.PubMedGoogle Scholar
  24. Shapiro S: Meta-analysis/Shmeta-analysis. Am J Epidemiol. 1994, 140: 771-778.PubMedGoogle Scholar
  25. Greenland S: Can meta-analysis be salvaged?. Am J Epidemiol. 1994, 140: 783-787.PubMedGoogle Scholar


© Duyndam et al.; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.